Literature DB >> 8653039

Early detection of prostate cancer. Role of prostate-specific antigen.

V M Prabhakaran1.   

Abstract

Pressure to request prostate-specific antigen (PSA) tests for early detection of prostate cancer in middle-aged and older men is increasing. However, current scientific data suggest that such testing does more harm than good. Most professional groups do not advise routine screening for prostate cancer. This paper reviews the current status of PSA testing.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8653039      PMCID： PMC2146418     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  6 in total

1.  Serum prostate-specific antigen: the most useful tumor marker.

Authors:  G L Andriole
Journal:  J Clin Oncol       Date:  1992-08       Impact factor: 44.544

Review 2.  To screen or not to screen?

Authors:  L J Denis
Journal:  Prostate Suppl       Date:  1992

Review 3.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

4.  Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.

Authors:  V S Ghali; E J Jimenez; R L Garcia
Journal:  Hum Pathol       Date:  1992-01       Impact factor: 3.466

Review 5.  A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team.

Authors:  J H Wasson; C C Cushman; R C Bruskewitz; B Littenberg; A G Mulley; J E Wennberg
Journal:  Arch Fam Med       Date:  1993-05

6.  Prostate specific antigen--a screening test for prostatic cancer?

Authors:  C S Powell; A M Fielding; K Rosser; A C Ames; K C Vaughton
Journal:  Br J Urol       Date:  1989-11
  6 in total
  1 in total

1.  Screening for prostate cancer: a controversy or fact.

Authors:  S Stavridis; S Saidi; Lj Lekovski; S Dohcev; G Spasovski
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.